dr. jeffrey jones on idelalisib and ibrutinib in patients with cll
Published 8 years ago • 274 plays • Length 2:14Download video MP4
Download video MP3
Similar videos
-
1:47
dr. jeffrey jones on efficacy of idelalisib/ofatumumab combination in cll
-
1:23
dr. jeffrey jones on idelalisib combinations in cll
-
1:16
dr. jones on long-term outcomes with ibrutinib in cll
-
1:33
dr. jeffrey jones on nccn recommendations for relapsed patients with cll
-
1:31
dr. jeffrey jones on the efficacy of venetoclax in treatment for cll
-
1:33
dr. zelenetz on treatment for patients with cll who fail on ibrutinib or idelalisib
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
1:25
idelalisib for previously treated cll
-
1:24
dr jones discusses ibrutinib/bendamustine/rituximab combination for cll
-
5:50
idelalisib in chronic lymphocytic leukemia
-
2:16
dr. jones on the efficacy of venetoclax in relapsed/refractory cll
-
1:29
dr. james on update of ibrutinib for chronic lymphocytic leukemia
-
1:17
dr. mato on managing side effects with ibrutinib/idelalisib in cll
-
7:13
using ibrutinib in chronic lymphocytic leukemia (cll)
-
11:28
adverse events of ibrutinib in chronic lymphocytic leukemia
-
3:46
the characteristics and mode of action of ibrutinib for cll
-
7:22
dr jeffrey jones (abstract s429)
-
9:02
efficacy and future role of ibrutinib in cll and mcl
-
2:27
real-world evidence of venetoclax vs ibrutinib vs idelalisib